Insights into N6-methyladenosine and programmed cell death in cancer

被引：0
作者：
Li Liu
Hui Li
Dingyu Hu
Yanyan Wang
Wenjun Shao
Jing Zhong
Shudong Yang
Jing Liu
Ji Zhang
机构：
[1] Shenzhen Traditional Chinese Medicine Hospital,Department of Clinical Laboratory
[2] Hengyang Medical School,The First Affiliated Hospital, Department of Rheumatology
[3] University of South China,Hunan Province Key Laboratory of Basic and Applied Hematology, Molecular Biology Research Center & Center for Medical Genetics
[4] School of Life Sciences,Department of Dermatology, Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Clinical Research Center for Cancer Immunotherapy
[5] Central South University,undefined
[6] Xiangya Hospital,undefined
[7] Central South University,undefined
[8] The First Affiliated Hospital,undefined
[9] Department of Hematology,undefined
[10] Hengyang Medical School,undefined
[11] University of South Chinal,undefined
来源：
Molecular Cancer | / 21卷
关键词：
N6-methyladenosine; Cancer; Apoptosis; Autophagy; Pyroptosis; Ferroptosis; Necroptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
N6-methyladenosine (m6A) methylation, the most common form of internal RNA modification in eukaryotes, has gained increasing attention and become a hot research topic in recent years. M6A plays multifunctional roles in normal and abnormal biological processes, and its role may vary greatly depending on the position of the m6A motif. Programmed cell death (PCD) includes apoptosis, autophagy, pyroptosis, necroptosis and ferroptosis, most of which involve the breakdown of the plasma membrane. Based on the implications of m6A methylation on PCD, the regulators and functional roles of m6A methylation were comprehensively studied and reported. In this review, we focus on the high-complexity links between m6A and different types of PCD pathways, which are then closely associated with the initiation, progression and resistance of cancer. Herein, clarifying the relationship between m6A and PCD is of great significance to provide novel strategies for cancer treatment, and has a great potential prospect of clinical application.
引用
收藏
相关论文
共 767 条
  • [61] Zhou N(2016)YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex Nat Commun 7 315-109.e9
  • [62] Li G(2015)N(6)-methyladenosine modulates messenger RNA translation efficiency Cell. 161 285-2014
  • [63] Kou Y(2017)Cytoplasmic m(6)A reader YTHDF3 promotes mRNA translation Cell Res 27 999-1000.e11
  • [64] Luo Y(2017)YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA Cell Res 27 1299-94
  • [65] Qing Y(2018)Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation Nat Cell Biol 20 560-764
  • [66] Dong L(2015)5′ UTR m(6)A promotes cap-independent translation Cell. 163 6051-5372
  • [67] Gao L(2015)HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events Cell. 162 18-16917
  • [68] Li C(2015)N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions Nature. 518 42271-1437
  • [69] Li Y(2017)N6-methyladenosine alters RNA structure to regulate binding of a low-complexity protein Nucleic Acids Res 45 640-957
  • [70] Han L(2013)ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility Mol Cell 49 1412-1235
234567891011